PCM
CELG

Prelude Capital Management’s Celgene Corp CELG Stock Holding History

Prelude Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-428,244
Closed -$42.5M – 2464
2019
Q3 		$42.5M Sell
428,244
-61,956
-13% -$5.89M 1.92% 4
2019
Q2 		$45.3M Sell
490,200
-12,538
-2% -$1.19M 2.23% 3
2019
Q1 		$47.4M Buy
502,738
+501,698
+48,240% +$43.9M 2.67% 2
2018
Q4 		$67K Sell
1,040
-1,686
-62% -$124K ﹤0.01% 1047
2018
Q3 		$244K Sell
2,726
-2,427
-47% -$214K 0.01% 718
2018
Q2 		$409K Sell
5,153
-2,257
-30% -$187K 0.03% 591
2018
Q1 		$661K Buy
7,410
+3,655
+97% +$351K 0.05% 371
2017
Q4 		$392K Sell
3,755
-15,946
-81% -$1.8M 0.03% 479
2017
Q3 		$2.87M Buy
19,701
+11,111
+129% +$1.51M 0.26% 82
2017
Q2 		$1.12M Buy
8,590
+6,273
+271% +$769K 0.11% 199
2017
Q1 		$288K Sell
2,317
-8,135
-78% -$974K 0.03% 445
2016
Q4 		$1.21M Buy
+10,452
New +$1.16M 0.15% 175
2016
Q1 		– Sell
-1,757
Closed -$210K – 1800
2015
Q4 		$210K Sell
1,757
-7,332
-81% -$848K 0.03% 543
2015
Q3 		$983K Buy
9,089
+2,989
+49% +$371K 0.14% 176
2015
Q2 		$706K Sell
6,100
-8,462
-58% -$967K 0.1% 231
2015
Q1 		$1.68M Buy
14,562
+4,422
+44% +$528K 0.23% 107
2014
Q4 		$1.13M Buy
10,140
+1,044
+11% +$110K 0.17% 135
2014
Q3 		$862K Buy
9,096
+1,054
+13% +$95.1K 0.12% 206
2014
Q2 		$691K Sell
8,042
-1,108
-12% -$84.3K 0.09% 279
2014
Q1 		$639K Buy
9,150
+2,514
+38% +$199K 0.09% 313
2013
Q4 		$561K Sell
6,636
-758
-10% -$60K 0.09% 312
2013
Q3 		$570K Sell
7,394
-10,138
-58% -$710K 0.09% 263
2013
Q2 		$1.02M Buy
+17,532
New +$1.06M 0.22% 105

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Prelude Capital Management's CELG Position: Q4 2019 in Review

Prelude Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 428,244 shares — an estimated $42.5M sold.

Prelude Capital Management first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $47.4M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Prelude Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Prelude Capital Management sold 428,244 Celgene Corp shares in Q4 2019, an estimated $42.5M.
  • Prelude Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Prelude Capital Management's Celgene Corp position peaked at $47.4M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.